Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN

NCT04743739 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped insufficient patient enrollment

Conditions

Idiopathic Membranous Nephropathy

Interventions

DRUG: Rituximab
DRUG: cyclosporine

Sponsor

Peking Union Medical College Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]